Imatinib (Gleevec) as a Paradigm of Targeted Cancer Therapies
Three lecture type video clips introduce
about Chronic Myeloid Leukemia (CML) and Imatinib. The first lecture presents historical perspective on CML, clinical description of CML, and development of Imatinib and its clinical trials. The second one introduces the mechanism of relapse of Imatinib. The third one discusses new therapies for patients with Imatinib resistance.
| Creator | |
|---|---|
| Publisher | |
| Intended Use | |
| Classification | |
| Resource Type | |
| Format | |
| Language | |
| Contributor | |
| Rights | http://www.ascb.org/ibioseminars/terms.cfm |
| Date Of Record Creation | 2008-05-29 12:11:16 |
| Date Of Record Release | 2008-05-29 12:11:16 |
| Date Last Modified | 2017-01-14 02:37:40 |
| Audience |
(no comments available yet for this resource)
Create a Login
Resource Comments